NO

Nick Olsen

Principal at Innovation Endeavors

San Francisco Bay Area

Overview 

Nick Olsen is currently an Investor at Innovation Endeavors in the San Francisco Bay Area, with a background in biomedical engineering and consulting. He has excelled in roles such as Principal and Senior Associate at Innovation Endeavors, demonstrating strong leadership and strategic skills in investing in companies at Series A and Seed stages within the BioTech sector.

Work Experience 

IE

Innovation Endeavors

  • Principal

    2023 - Current

    investing in biotech and healthcare

  • Senior Associate

    2022 - 2023

  • Associate

    2021 - 2021

Innovation Endeavors invests in visionary founders, transformational technology, and emergent ecosystems for a new world.

innovationendeavors.com
CB

Character Biosciences

  • Member Board of Directors

    2025

AT

Averna Therapeutics

  • Member Board of Directors

    2024

TL

Tempus Labs, Inc.

  • Strategy and Operations

    2018 - 2021

    Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions and deliver personalized patient care.

B&

Bain & Company

  • Associate Consultant, Senior Associate Consultant

    2015 - 2018

ST

Spark Therapeutics, Inc.

  • Global Commercial

    2017 - 2017

Spark Therapeutics is focused on the development of treatments for genetic diseases.

Raised $763,800,000.00 from Brookside Capital, Sofinnova Investments, Deerfield, Rock Springs Capital, T. Rowe Price and Wellington Management.

sparktx.com

Education 

Articles About Nick

Relevant Websites